Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.25.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Net revenues $ 18,685,845 $ 13,036,172
Operating expenses:    
Direct costs of revenues 7,574,548 6,767,921
General and administrative expenses 9,435,031 7,217,405
Depreciation and amortization 310,528 469,371
Total operating expenses 17,320,107 14,454,697
Income (loss) from continuing operations before other income (expense), income taxes and net loss attributable to noncontrolling interest 1,365,738 (1,418,525)
Other income (expense):    
Other income, net 1,151,754 433,353
Gain from forgiveness of debt 200,000 334,819
Loss from legal settlements, net (755,117) (129,153)
Change in fair value of investment (823,596)
Interest expense (1,452,823) (2,257,544)
Total other income (expense), net (1,679,782) (1,618,525)
Net loss from continuing operations before income taxes, including noncontrolling interest (314,044) (3,037,050)
Provision for income taxes (239,834) (312,849)
Net loss from continuing operations, including noncontrolling interest (553,878) (3,349,899)
(Loss) income from discontinued operations (7,195,076) 56,844
Net loss, including noncontrolling interest (7,748,954) (3,293,055)
Net loss attributable to noncontrolling interest 19,793
Net loss attributable to Rennova (7,729,161) (3,293,055)
Deemed dividends (330,876,369)
Net loss available to common stockholders $ (7,729,161) $ (334,169,424)
Net loss per share of common stock available to common stockholders- basic and diluted    
Continuing operations - basic $ (0.00) $ (0.03)
Continuing operations - diluted (0.00) (0.03)
Discontinued operations - basic (0.00) 0.00
Discontinued operations - diluted (0.00) 0.00
Total basic (0.00) (0.03)
Total diluted $ (0.00) $ (0.03)
Weighted average number of shares of common stock outstanding during the period:    
Basic 32,825,519,517 9,992,238,468
Diluted 32,825,519,517 9,992,238,468